A nasty rash isn’t the only thing this shot may spare you from. A new study from the University of Southern California found ...

ATLANTA, GA, Oct. 11, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, today ...

It’s fall, which means it’s time to get updated on the winter season shots. That includes vaccines for flu, RSV (for babies and the elderly) and, for anyone six months or older, COVID-19. While the ...

Most COVID-19 vaccine hesitancy is rooted in concerns that can be addressed and effectively reduced over time, according to a ...

Findings reveal a general decline in vaccine hesitancy during the 15 months following the COVID-19 vaccine roll-out in 2021-2022, with almost two-thirds of those initially hesitant going on to receive ...

An analysis of more than one million people in the UK found that two-thirds of people who were vaccine-hesitant during the ...